	Srodki Pieniężne I Ekwiwalent		Data
Acadia Pharmaceuticals	USD 847.02M	85.02M	2025-09
Akebia Therapeutics	USD 166.44M	29.14M	2025-09
ALKERMES	USD 616.45M	95.25M	2025-09
Alnylam Pharmaceuticals	USD 1.66B	167M	2025-12
Amarin	USD 122.8M	25.08M	2025-09
ANI Pharmaceuticals	USD 262.61M	44.81M	2025-09
BioMarin Pharmaceutical	USD 1.25B	36.29M	2025-09
Coherus Biosciences	USD 103.35M	113.54M	2025-09
Emergent BioSolutions	USD 111.7M	23.9M	2023-12
Exact Sciences	USD 956M	166.96M	2025-12
Exelixis	USD 482.49M	106.19M	2025-12
Glaxosmithkline	GBP 3.3B	303M	2025-09
Heron Therapeutics	USD 43.07M	26.55M	2025-09
Ionis Pharmaceuticals	USD 2.24B	1.94B	2025-09
Ironwood Pharmaceuticals	USD 140.41M	47.56M	2025-09
Lexicon Pharmaceuticals	USD 21.36M	41.52M	2025-06
Lonza	CHF 1.11B	286M	2024-12
Merck	USD 18.17B	10.16B	2025-09
Moderna	USD 2.6B	1.46B	2025-12
Myriad Genetics	USD 145.4M	71M	2025-09
Nektar Therapeutics	USD 41.03M	1.96M	2025-09
Neurocrine Biosciences	USD 713M	372.8M	2025-12
Pacira	USD 147.59M	152.89M	2025-09
Pfizer	USD 1.34B	295M	2025-09
PTC Therapeutics	USD 672.62M	344.77M	2025-09
Sanofi	EUR 7.66B	1.25B	2025-12
Sarepta Therapeutics	USD 613.08M	102.48M	2025-09
United Therapeutics	USD 1.34B	253M	2025-09
Vanda Pharmaceuticals	USD 84.85M	14.83M	2025-12
Xoma	USD 143.9M	7.68M	2024-06

Emergent BioSolutions Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.